These two get mentioned in the same breath constantly — plant medicines, traditional origins, profound experiences, people coming back changed. So it’s reasonable to assume they’re variations on the same thing and the choice is a matter of preference.
They are not the same thing, and for one specific situation the difference is enormous.
Here’s the short version: if you are physically dependent on opioids, ibogaine and ayahuasca are not interchangeable options. Ibogaine interrupts opioid withdrawal. Ayahuasca does not, and cannot. Someone in fentanyl withdrawal at an ayahuasca retreat is simply someone in fentanyl withdrawal at an ayahuasca retreat.
Everything below explains why, and where each one genuinely does belong.
Where they come from
Iboga comes from the root bark of Tabernanthe iboga, a shrub native to West and Central Africa. It has been used for centuries in the Bwiti tradition of Gabon and neighbouring regions, primarily in initiation ceremonies — long, inward, often solitary experiences lasting a full day or more. Ibogaine is the principal alkaloid, and it’s what most clinics administer in isolated form.
Ayahuasca is an Amazonian brew, traditionally combining the Banisteriopsis caapi vine with a DMT-containing plant such as Psychotria viridis. The vine contains MAO inhibitors that make the DMT orally active. It sits at the centre of numerous indigenous and syncretic traditions across Peru, Brazil, Colombia and Ecuador, usually taken in group ceremony, at night, guided by song.
Different continents, different plants, different pharmacology, different purposes.
What they actually do in the body
Ayahuasca works mainly through serotonin. DMT acts on 5-HT2A receptors — the same broad pathway as psilocybin and LSD — while the MAO inhibitors keep it active long enough to be absorbed orally. The experience typically lasts four to six hours, and most retreats run several ceremonies across a week.
Ibogaine is pharmacologically much stranger. It acts on opioid receptors, NMDA receptors, sigma receptors, serotonin transporters and nicotinic receptors — a genuinely unusual profile that researchers are still working out. A session lasts 24 to 36 hours, and its metabolite noribogaine stays active for days to weeks afterward.
That receptor activity is the whole reason ibogaine occupies a different category. It doesn’t just produce an experience. It acts directly on the systems that opioid dependence lives in.
The difference that matters most
If your situation involves physical dependence — opioids, fentanyl, methadone, Suboxone, 7-OH — this is the section that decides it.
Ibogaine interrupts withdrawal. Most people report the majority of withdrawal symptoms resolving within a day of the session, and cravings dropping sharply. Whatever else is or isn’t true about ibogaine, this effect is consistent, well documented, and not something any other psychedelic produces.
Ayahuasca does nothing for withdrawal. It’s not a criticism of ayahuasca — it was never meant to. But it means an opioid-dependent person arriving at a retreat faces an impossible situation: use during the retreat, or go into withdrawal in a setting with no medical detox, no comfort medications, and often no doctor. Neither goes well.
There’s also a real safety issue that gets far too little attention. The MAO inhibitors in ayahuasca interact dangerously with a long list of substances, including some opioids and many antidepressants. Combining them can cause serotonin syndrome, which can be fatal. Anyone considering ayahuasca while taking anything at all needs to disclose it and be screened properly.
What the experiences are actually like
People who’ve done both tend to describe them as fundamentally different in character.
Ayahuasca is usually visionary and emotional. Powerful imagery, waves of feeling, often physical purging, and a strong sense of ceremony — you’re in a room with other people, with music, being held through it. Many describe it as an encounter with something outside themselves.
Ibogaine is more often described as a waking dream, or as watching a film of your own life. People lie still for many hours, and what comes tends to be autobiographical: memories, scenes, relationships, decisions, viewed with unusual detachment. It’s frequently described as reviewing rather than journeying. Less overwhelming in feeling, more relentless in content.
Neither is pleasant, exactly. Both are work.
Safety: two different risk profiles
Ibogaine’s main risk is cardiac. It prolongs the QT interval and can, in the wrong circumstances, cause a fatal arrhythmia. This is a serious risk, and it’s the reason ibogaine belongs in a medical setting with cardiac screening, electrolyte correction and continuous monitoring. It is also largely predictable and largely preventable — we cover exactly how on our ibogaine safety page.
Ayahuasca’s main risks are interactions and psychological. The MAOI content makes drug and dietary interactions genuinely dangerous. Deaths at retreats have occurred, often involving other substances or undiagnosed conditions. And because ayahuasca is usually taken in ceremonial rather than clinical settings, medical screening ranges from thorough to nonexistent depending entirely on who’s running it.
Different dangers. Both real. Both mostly about screening and setting rather than the plant itself.
So which one
Ayahuasca may make sense if you’re not physically dependent on anything, you’re working with trauma, grief, depression or a sense of disconnection, and you’re drawn to a ceremonial and communal approach. It suits repeated work over time.
Ibogaine may make sense if you’re physically dependent on opioids or other substances and need the withdrawal interrupted, you’ve been through detox before and it didn’t hold, or you want the psychological opening but need it to happen in a medically supervised setting.
Neither is appropriate if you have a cardiac condition (ibogaine), you’re on medications that interact and can’t be safely managed, or you’re hoping the experience alone will do the work.
That last one is worth saying plainly, because it applies equally to both. Neither of these is a cure. Both open something. What determines the outcome is what happens in the weeks afterward — and that’s the part almost nobody plans for.
Can you do both?
Some people do, and there’s no fundamental reason not to — but not close together, and not without medical guidance.
Ibogaine’s cardiac effects persist for days after a session, and ayahuasca’s MAOI content is exactly the kind of thing you don’t want interacting with that. Leave real time between them, and tell whoever is running the second one what you did first. People routinely don’t, and that omission is how avoidable things go wrong.
The thing both have in common
Here’s what we’ve learned watching people come through this work for years.
The experience is rarely the problem. People have profound sessions all the time. What separates the ones who change from the ones who don’t isn’t what happened during the ceremony — it’s whether there was any structure afterward for the insight to land in.
A weekend retreat and a flight home on Monday wastes most of what just happened. So does a one-week ibogaine program. The window that opens stays open for weeks, and it closes whether or not you used it.
That’s why our programs run weeks rather than days, and why the time after the session is the part we actually built the clinic around.
If you’re trying to decide
If you’re weighing these two and you’re not sure which fits your situation, call us at (877) 876-4157. If what you’re describing sounds more like ayahuasca’s territory than ours, we’ll tell you that — we’d rather send you to the right thing than book you into the wrong one.
Free and confidential, and there’s nothing to buy.
This page is general information and is not medical advice. Both ibogaine and ayahuasca carry real risks and require proper medical screening.